samedan logo

 
 
spacer
home > ebr > winter 2003 > in conversation with mary harney
PUBLICATIONS
European Biopharmaceutical Review

In conversation with Mary Harney

Mary Harney is the Irish Deputy Prime Minister and Minister for Enterprise Trade and Employment. She has had a direct hand in driving Ireland's recent impressive science research foundation programmes, identified as critical if Ireland was to underpin an emerging biotechnology industry on the back of decades of inward investment in pharmaceutical manufacturing expertise. A Tainiste, to give Mrs Harney her true political title in Ireland, is equally outspoken on the importance of knowledge-based industry - and biotechnology in particular - to future European economic growth along with the need for political will to replace rhetoric at the highest level. As incoming President of the EU Competitiveness Council, which oversees the EU's life sciences biotechnology strategy, Mrs Harney represented the most relevant and senior of political commentators to bring the political message at the Opening Plenary session of the CORDIA-EuropaBio Convention in December 2003.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Ireland Makes its Mark in Europe in the Opening Session of the Inaugural CORDIA-EuropaBio Convention, Vienna, December 2003

By Dr Helen Abbott, Chair Editorial Board of EBR and Member of Executive Steering Group, CORDIA-EuropaBio Convention 2003

spacer
Mary Harney
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Joins the Association of Clinical Research Organizations (ACRO) to Add a Technology Perspective to Conversations with Legislators and Industry Leaders about the Future of Clinical Research

PHILADELPHIA, PA November 21, 2019: Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO). ACRO, a global coalition of research and technology companies, makes it their mission to advocate as the collective voice of the innovative clinical research industry to regulators and policymakers, educating stakeholders and shaping policies that foster efficient, effective and safe conduct of clinical research.
More info >>

White Papers

Personalised Medicine - Pharma and Dx Firms Share Wider Horizons

DiagnostikNet-BB

Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

23-26 March 2020, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 23 – 26 March 2020. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement